Clinical Trial Details

EORTC-30962

Back to Clinical Trials Database

Comparative study of intravesical BCG standard dose long-term maintenance versus BCG 1/3 dose long-term maintenance versus BCG standard dose short-term maintenance versus BCG 1/3 dose short-term maintenance in intermediate and high risk Ta- T1 Papillary Carcinoma of the Urinary Bladder.

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 01-Mar-1997
Date Step1 close: 04-Apr-2005
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 1288
Treatment
Study Staff
Type of cancer
Participating groups EORTC Genito-Urinary Cancers Group
Protocol summary http://clinicaltrials.gov/ct/show/NCT00002990
NCT number NCT00002990